Please enable JavaScript to continue using this application.

Compare $BRKR vs $TXG | Chartloom

Compare

$BRKR vs $TXG

Bruker Corp · 10X Genomics Inc

BRKR

Bruker Corp

TXG

10X Genomics Inc

Compare $BRKR vs $TXG

Comparing Bruker Corp and 10X Genomics Inc

BRKRBruker Corp

TXG10X Genomics Inc

BRKRBruker Corp

Market cap

$8.96B

P/E (TTM)

—

Forward P/E (NTM)

25.41x

Forward P/S (NTM)

2.43x

Rev growth (TTM)

1.6%

YTD performance

22.3%

52W performance

69.9%

FCF yield

0.7%

TXG10X Genomics Inc

Market cap

$10.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

15.72x

Rev growth (TTM)

-4.3%

YTD performance

385.3%

52W performance

568.2%

FCF yield

1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BRKR

TXG

Detailed metrics comparison

BRKR

Bruker Corp

TXG

10X Genomics Inc

Market Cap

BRKR$8.96B

TXG$10.24B

Enterprise Value

BRKR$10.60B

TXG$9.74B

Price

BRKR$58.84

TXG$80.65

P/E Ratio

BRKRN/A

TXGN/A

P/S Ratio

BRKR2.56x

TXG16.60x

EV/Sales

BRKR3.03x

TXG15.78x

EV/EBITDA

BRKR19.99x

TXG0.00x

P/B Ratio

BRKR4.05x

TXG14.76x

P/FCF Ratio

BRKR138.23x

TXG84.32x

EV/FCF

BRKR163.54x

TXG80.18x

PEG Ratio

BRKRN/A

TXGN/A

Forward P/E (NTM)

BRKR25.41x

TXGN/A

Forward P/S (NTM)

BRKR2.43x

TXG15.72x

Revenue (TTM)

BRKR$3.50B

TXG$617M

Revenue Growth (YoY)

BRKR1.6%

TXG-4.3%

Forward Rev Growth

BRKR4.0%

TXG9.4%

Gross Margin (TTM)

BRKR47.7%

TXG69.6%

Operating Margin (TTM)

BRKR0.0%

TXG0.0%

EBITDA Margin (TTM)

BRKR15.1%

TXG-7.8%

Net Margin (TTM)

BRKR-3.1%

TXG-12.2%

FCF Margin (TTM)

BRKR1.9%

TXG19.7%

Net Income (TTM)

BRKR$-107M

TXG$-75M

FCF (TTM)

BRKR$65M

TXG$121M

EPS (TTM)

BRKR-$0.70

TXG-$0.58

ROE (TTM)

BRKR-293.0%

TXG-933.0%

ROA (TTM)

BRKR-115.0%

TXG-730.0%

ROIC (TTM)

BRKR-167.0%

TXG-933.0%

Cash

BRKR$185M

TXG$503M

Debt

BRKR$1.82B

TXG$0

Net Cash/Debt

BRKR$-1.64B

TXG$503M

Current Ratio (TTM)

BRKR1.85x

TXG5.69x

Quick Ratio (TTM)

BRKR0.88x

TXG5.09x

Debt/Equity (TTM)

BRKR0.77x

TXG0.00x

Debt/Assets (TTM)

BRKR0.0%

TXG0.0%

Interest Coverage (TTM)

BRKRN/A

TXGN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

TXG0.00x

Beta

BRKR1.24

TXG2.01

52W Performance

BRKR69.9%

TXG568.2%

YTD Performance

BRKR22.3%

TXG385.3%

% from 52W High

BRKR-12.2%

TXG-21.6%

% from 52W Low

BRKR81.8%

TXG622.7%

Asset Turnover (TTM)

BRKR0.56x

TXG0.60x

FCF Yield (TTM)

BRKR0.7%

TXG1.2%

Earnings Yield (TTM)

BRKR-1.2%

TXG-0.7%

Dividend Yield (TTM)

BRKR0.6%

TXGN/A

Rule of 40

BRKR3.5

TXG15.4

EV/GP/RG

BRKR1.17

TXG4.06

Ticker research

View BRKR research View TXG research

Metric	BRKR Bruker Corp	TXG 10X Genomics Inc
Market & Valuation
Market Cap	$8.96B	$10.24B
Enterprise Value	$10.60B	$9.74B
Price	$58.84	$80.65
P/E Ratio	N/A	N/A
P/S Ratio	2.56x	16.60x
EV/Sales	3.03x	15.78x
EV/EBITDA	19.99x	0.00x
P/B Ratio	4.05x	14.76x
P/FCF Ratio	138.23x	84.32x
EV/FCF	163.54x	80.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.41x	N/A
Forward P/S (NTM)	2.43x	15.72x
Revenue & Growth
Revenue (TTM)	$3.50B	$617M
Revenue Growth (YoY)	1.6%	-4.3%
Forward Rev Growth	4.0%	9.4%
Profitability
Gross Margin (TTM)	47.7%	69.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	15.1%	-7.8%
Net Margin (TTM)	-3.1%	-12.2%
FCF Margin (TTM)	1.9%	19.7%
Net Income (TTM)	$-107M	$-75M
FCF (TTM)	$65M	$121M
EPS (TTM)	-$0.70	-$0.58
ROE (TTM)	-293.0%	-933.0%
ROA (TTM)	-115.0%	-730.0%
ROIC (TTM)	-167.0%	-933.0%
Financial Health
Cash	$185M	$503M
Debt	$1.82B	$0
Net Cash/Debt	$-1.64B	$503M
Current Ratio (TTM)	1.85x	5.69x
Quick Ratio (TTM)	0.88x	5.09x
Debt/Equity (TTM)	0.77x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	2.01
52W Performance	69.9%	568.2%
YTD Performance	22.3%	385.3%
% from 52W High	-12.2%	-21.6%
% from 52W Low	81.8%	622.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.60x
FCF Yield (TTM)	0.7%	1.2%
Earnings Yield (TTM)	-1.2%	-0.7%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	15.4
EV/GP/RG	1.17	4.06
Ticker research	View BRKR research	View TXG research

Valuation

P/S Ratio

BRKR

2.56x

TXG

16.60x

EV/FCF

TXG

80.18x

BRKR

163.54x

Growth & revenue

Revenue Growth TTM

BRKR

1.6%

TXG

-4.3%

Forward Revenue Growth

TXG

9.4%

BRKR

4.0%

Profitability & performance

Gross Margin

TXG

69.6%

BRKR

47.7%

ROE

BRKR

-293.0%

TXG

-933.0%

FCF Yield %

TXG

1.2%

BRKR

0.7%

52-Week Performance

TXG

568.2%

BRKR

69.9%

Detailed metrics comparison

BRKR

Bruker Corp

TXG

10X Genomics Inc

Market Cap

BRKR$8.96B

TXG$10.24B

Enterprise Value

BRKR$10.60B

TXG$9.74B

Price

BRKR$58.84

TXG$80.65

P/E Ratio

BRKRN/A

TXGN/A

P/S Ratio

BRKR2.56x

TXG16.60x

EV/Sales

BRKR3.03x

TXG15.78x

EV/EBITDA

BRKR19.99x

TXG0.00x

P/B Ratio

BRKR4.05x

TXG14.76x

P/FCF Ratio

BRKR138.23x

TXG84.32x

EV/FCF

BRKR163.54x

TXG80.18x

PEG Ratio

BRKRN/A

TXGN/A

Forward P/E (NTM)

BRKR25.41x

TXGN/A

Forward P/S (NTM)

BRKR2.43x

TXG15.72x

Revenue (TTM)

BRKR$3.50B

TXG$617M

Revenue Growth (YoY)

BRKR1.6%

TXG-4.3%

Forward Rev Growth

BRKR4.0%

TXG9.4%

Gross Margin (TTM)

BRKR47.7%

TXG69.6%

Operating Margin (TTM)

BRKR0.0%

TXG0.0%

EBITDA Margin (TTM)

BRKR15.1%

TXG-7.8%

Net Margin (TTM)

BRKR-3.1%

TXG-12.2%

FCF Margin (TTM)

BRKR1.9%

TXG19.7%

Net Income (TTM)

BRKR$-107M

TXG$-75M

FCF (TTM)

BRKR$65M

TXG$121M

EPS (TTM)

BRKR-$0.70

TXG-$0.58

ROE (TTM)

BRKR-293.0%

TXG-933.0%

ROA (TTM)

BRKR-115.0%

TXG-730.0%

ROIC (TTM)

BRKR-167.0%

TXG-933.0%

Cash

BRKR$185M

TXG$503M

Debt

BRKR$1.82B

TXG$0

Net Cash/Debt

BRKR$-1.64B

TXG$503M

Current Ratio (TTM)

BRKR1.85x

TXG5.69x

Quick Ratio (TTM)

BRKR0.88x

TXG5.09x

Debt/Equity (TTM)

BRKR0.77x

TXG0.00x

Debt/Assets (TTM)

BRKR0.0%

TXG0.0%

Interest Coverage (TTM)

BRKRN/A

TXGN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

TXG0.00x

Beta

BRKR1.24

TXG2.01

52W Performance

BRKR69.9%

TXG568.2%

YTD Performance

BRKR22.3%

TXG385.3%

% from 52W High

BRKR-12.2%

TXG-21.6%

% from 52W Low

BRKR81.8%

TXG622.7%

Asset Turnover (TTM)

BRKR0.56x

TXG0.60x

FCF Yield (TTM)

BRKR0.7%

TXG1.2%

Earnings Yield (TTM)

BRKR-1.2%

TXG-0.7%

Dividend Yield (TTM)

BRKR0.6%

TXGN/A

Rule of 40

BRKR3.5

TXG15.4

EV/GP/RG

BRKR1.17

TXG4.06

Ticker research

View BRKR research View TXG research

Metric	BRKR Bruker Corp	TXG 10X Genomics Inc
Market & Valuation
Market Cap	$8.96B	$10.24B
Enterprise Value	$10.60B	$9.74B
Price	$58.84	$80.65
P/E Ratio	N/A	N/A
P/S Ratio	2.56x	16.60x
EV/Sales	3.03x	15.78x
EV/EBITDA	19.99x	0.00x
P/B Ratio	4.05x	14.76x
P/FCF Ratio	138.23x	84.32x
EV/FCF	163.54x	80.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.41x	N/A
Forward P/S (NTM)	2.43x	15.72x
Revenue & Growth
Revenue (TTM)	$3.50B	$617M
Revenue Growth (YoY)	1.6%	-4.3%
Forward Rev Growth	4.0%	9.4%
Profitability
Gross Margin (TTM)	47.7%	69.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	15.1%	-7.8%
Net Margin (TTM)	-3.1%	-12.2%
FCF Margin (TTM)	1.9%	19.7%
Net Income (TTM)	$-107M	$-75M
FCF (TTM)	$65M	$121M
EPS (TTM)	-$0.70	-$0.58
ROE (TTM)	-293.0%	-933.0%
ROA (TTM)	-115.0%	-730.0%
ROIC (TTM)	-167.0%	-933.0%
Financial Health
Cash	$185M	$503M
Debt	$1.82B	$0
Net Cash/Debt	$-1.64B	$503M
Current Ratio (TTM)	1.85x	5.69x
Quick Ratio (TTM)	0.88x	5.09x
Debt/Equity (TTM)	0.77x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	2.01
52W Performance	69.9%	568.2%
YTD Performance	22.3%	385.3%
% from 52W High	-12.2%	-21.6%
% from 52W Low	81.8%	622.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.60x
FCF Yield (TTM)	0.7%	1.2%
Earnings Yield (TTM)	-1.2%	-0.7%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	15.4
EV/GP/RG	1.17	4.06
Ticker research	View BRKR research	View TXG research